Pricing Log in Create free account

BioAtla, Inc. (BCAB) vs Ernexa Therapeutics Inc. (ERNA)

BioAtla, Inc. and Ernexa Therapeutics Inc. are both Biotechnology companies. BioAtla, Inc. and Ernexa Therapeutics Inc. are of similar size ($3.0M and $2.9M). BioAtla, Inc. grew revenue faster over the last twelve months: 574.7% against −78.6%. Ernexa Therapeutics Inc. has the higher net margin (0.00% vs −177.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, BioAtla, Inc. leads on 8 and Ernexa Therapeutics Inc. on 7.

Valuation

Metric BCAB ERNA Biotechnology median
P/E n/m n/m 10.60
P/S 0.19 3.82 9.40
P/B n/m 0.70 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.69 50.76 9.02
Earnings yield (1,272.50%) (992.55%) (32.88%)
Free cash flow yield (709.98%) (399.18%) (23.13%)

Profitability

Metric BCAB ERNA Biotechnology median
Gross margin 95.44% 83.51% 68.51%
Operating margin (180.99%) 0.00% 0.00%
Net margin (177.21%) 0.00% 0.00%
Free cash flow margin (132.29%) 0.00% 0.00%
Return on equity 118.74% (321.22%) (51.96%)
Return on assets (171.72%) (176.62%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCAB ERNA Biotechnology median
Revenue growth (TTM) 574.65% (78.60%) 6.76%
EPS growth (last fiscal year) 29.86% 95.42% 29.88%
Revenue growth, 5-year CAGR (28.40%) (52.20%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCAB ERNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.20 2.01 4.97
Net debt to EBITDA 0.12 0.21 1.01

Dividend

Metric BCAB ERNA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCAB ERNA Biotechnology median
Market cap 2.89m 2.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack